Steven A. Weitzel

Mr. Weitzel received his Masters in Business Administration at Washington University in St. Louis and his B.S. in Chemical Engineering from the University of Missouri.

Steve has been the Director of Marketing at Novaflux Technologies since 1998, responsible for business development and commercialization contacts. Also serving as Validation Director, his technical duties include applications development, process validation and regulatory compliance and FDA submissions for the company's core technologies including low temperature sterilization, medical device decontamination, and disinfection and cleaning of purification membranes and process equipment.

Steve has over 20 years experience in FDA regulated industry in engineering, operations, marketing and validation for pharmaceuticals, medical devices and diagnostics, bulk compounds and personal care products including Dow Chemical, Mallinckrodt Medical, and divisions of Merck and Bristol-Myers Squibb. He was recently responsible for technical operations for a chemical company making medical/scientific cleaning agents for AMSCO and Castle-MDT. He managed international technical marketing for Calgon Vestal (now Steris) and started up their pharmaceutical contamination control group, developed and introduced their CIP product line, managed and expanded disinfectant and sterilant products (Spor-Klenz, Septihol, LpHst), was responsible for cGMP training programs and for cleaning validation support and services.

Steve is a member of PDA and the International Society for Pharmaceutical Engineering. As a recognized expert in the field of FDA regulated contamination control, he has consulted or conducted seminars or training for the world's leading pharmaceutical, biotech and medical device companies, and has made numerous technical presentations on the topics of cGMP compliance, cleaning validation, contamination control and infection control.